Cargando…
Effects of the Delta Opioid Receptor Agonist DADLE in a Novel Hypoxia-Reoxygenation Model on Human and Rat-Engineered Heart Tissue: A Pilot Study
Intermittent hypoxia and various pharmacological compounds protect the heart from ischemia reperfusion injury in experimental approaches, but the translation into clinical trials has largely failed. One reason may lie in species differences and the lack of suitable human in vitro models to test for...
Autores principales: | Funcke, Sandra, Werner, Tessa R., Hein, Marc, Ulmer, Bärbel M., Hansen, Arne, Eschenhagen, Thomas, Hirt, Marc N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565486/ https://www.ncbi.nlm.nih.gov/pubmed/32932811 http://dx.doi.org/10.3390/biom10091309 |
Ejemplares similares
-
Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue
por: Görbe, A., et al.
Publicado: (2015) -
Delta Opioid Peptide [d-Ala2, d-Leu5] Enkephalin (DADLE) Exerts a Cytoprotective Effect in Astrocytes Exposed to Oxygen-Glucose Deprivation by Inducing Autophagy
por: Wang, Shuyan, et al.
Publicado: (2019) -
Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue
por: Werner, Tessa R., et al.
Publicado: (2019) -
Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density
por: Lemoine, Marc D., et al.
Publicado: (2017) -
Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes
por: Ulmer, Bärbel M., et al.
Publicado: (2018)